Nutra Pharma Corp.
NPHC · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | -$20 | $10 | $7 | $91 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $295 | $362 | $337 | $325 |
| Inventory | $49 | $42 | $64 | $31 |
| Other Curr. Assets | $118 | $91 | $88 | $86 |
| Total Curr. Assets | $462 | $505 | $496 | $534 |
| Property Plant & Equip (Net) | $129 | $150 | $172 | $139 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $99 | $101 | $107 | $108 |
| Total NC Assets | $228 | $252 | $280 | $246 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $691 | $757 | $776 | $780 |
| Liabilities | – | – | – | – |
| Payables | $713 | $666 | $737 | $672 |
| Short-Term Debt | $7,903 | $8,300 | $7,076 | $7,678 |
| Tax Payable | $228 | $222 | $219 | $216 |
| Deferred Revenue | $111 | $110 | $141 | $2,253 |
| Other Curr. Liab. | $7,193 | $7,442 | $8,020 | $10,322 |
| Total Curr. Liab. | $16,148 | $16,740 | $16,192 | $21,140 |
| LT Debt | $152 | $214 | $358 | $517 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $152 | $214 | $358 | $517 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $20 | $40 | $59 | $78 |
| Total Liabilities | $16,300 | $16,954 | $16,550 | $21,658 |
| Equity | – | – | – | – |
| Pref Stock | $12 | $12 | $12 | $12 |
| Common Stock | $7,597 | $7,586 | $7,364 | $7,331 |
| Retained Earnings | -$76,784 | -$77,361 | -$76,716 | -$81,729 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $53,566 | $53,566 | $53,566 | $53,508 |
| Total Equity | -$15,610 | -$16,197 | -$15,774 | -$20,878 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $691 | $757 | $776 | $780 |
| Net Debt | $8,075 | $8,503 | $7,427 | $8,104 |